Feng Peng
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 15
- Cancer-related molecular mechanisms research 13
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 14
- Molecular Biology top 10%
- RNA modifications and cancer 11
- Metabolism, Diabetes, and Cancer 10
-
- Gastric Cancer Management and Outcomes 16
- Lung Cancer Treatments and Mutations 12
- Surgery top 10%
- Esophageal Cancer Research and Treatment 9
- Co-authors
- Jinxiu LinWenquan NiuJianxin JiangXingjun GuoXiandong LinHejun ZhangXiongwei ZhengMin Wang
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Feng Peng
123 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 123
- Cancer Research 633
- Oncology 494
- Molecular Biology 952
- Pulmonary and Respiratory Medicine 397
- Surgery 414
Countries citing papers authored by Feng Peng
This map shows the geographic impact of Feng Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Peng more than expected).
Fields of papers citing papers by Feng Peng
This network shows the impact of papers produced by Feng Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Peng. The network helps show where Feng Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Feng Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 32 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2020 | 5 | |
| 7 | 2020 | 13 | |
| 8 | 2020 | 38 | |
| 9 | 2020 | 21 | |
| 10 | 2018 | 11 | |
| 11 | SIRT1 gene polymorphisms and risk of lung cancer | 2017 | 1 |
| 12 | 2017 | 29 | |
| 13 | 2016 | 18 | |
| 14 | 2016 | 32 | |
| 15 | 2014 | 16 | |
| 16 | 2013 | 31 | |
| 17 | 2013 | 42 | |
| 18 | 2013 | 88 | |
| 19 | 2011 | 5 | |
| 20 | 2009 | 7 |
About Feng Peng
Feng Peng is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 127 papers that have together received 2.0k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (16 papers), Cancer, Lipids, and Metabolism (15 papers), Pancreatic and Hepatic Oncology Research (14 papers), Cancer-related molecular mechanisms research (13 papers), Lung Cancer Treatments and Mutations (12 papers), RNA modifications and cancer (11 papers), Metabolism, Diabetes, and Cancer (10 papers) and Esophageal Cancer Research and Treatment (9 papers). The work is most often cited by research in Cancer Research (633 citations), Oncology (494 citations) and Molecular Biology (952 citations). Feng Peng has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jinxiu Lin, Wenquan Niu, Jianxin Jiang, Xingjun Guo, Xiandong Lin, Hejun Zhang, Xiongwei Zheng, Min Wang, Ming Shen and Chengjian Shi. Their work appears in journals such as Journal of Cancer, Frontiers in Oncology, PLoS ONE, Oncotarget and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.